Chemren Bio-Engineering Co., Ltd.

Products > Receptor Tyrosine Kinases > c-Met > Tivantinib(ARQ197)
Product name : Tivantinib(ARQ197)
Item : CR1170
CAS : 905854-02-6
 Enlarge Image                   Back
←[Previous Product]             


Details:
Description of:Tivantinib(ARQ197)
Exposure to ARQ197(Tivantinib) resulted in the inhibition of proliferation of c-Met–expressing cancer cell lines as well as the induction of caspase-dependent apoptosis in cell lines with constitutive c-Met activity. These cellular responses to ARQ197(Tivantinib) were phenocopied by RNAi-mediated c-Met depletion and further demonstrated by the growth inhibition of human tumors following oral administration of ARQ197(Tivantinib) in multiple mouse xenograft efficacy studies. 

Theoretical analysis:Tivantinib(ARQ197)
MF:C23H19N3O2
MW:369.42
Purity:99%
Solubility:unknow
CAS No: 905854-02-6

Availability and price:Tivantinib(ARQ197)
Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to : sales@chemrenpharm.com

Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days


Related Products :
Tyrosine kinase inhibitor
Tyrosine kinase inhibitor
PHA-665752
PHA-665752
JNJ38877605
JNJ38877605
PF-04217903
PF-04217903
EMD1214063
EMD1214063
BMS777607
BMS777607
MGCD-265
MGCD-265
AMG208
AMG208

Online service

点击这里给我发消息